Aethlon Medical annual operating margin
2012
2013
2014
2015
2016
2017
2018
2019
2020
2021
2022
2023
Aethlon Medical's operating margin was −2,072.05% for fiscal 2023.
View full Aethlon Medical company overview| Fiscal year | Period ended | Operating margin | Change (percentage points) |
|---|---|---|---|
| 2023 | 2023-03-31 | −2,072.05% | +1470.48 pp |
| 2022 | 2022-03-31 | −3,542.53% | −2345.22 pp |
| 2021 | 2021-03-31 | −1,197.31% | −285.26 pp |
| 2020 | 2020-03-31 | −912.04% | +1700.48 pp |
| 2019 | 2019-03-31 | −2,612.53% | +616.29 pp |
| 2018 | 2018-03-31 | −3,228.82% | −1673.40 pp |
| 2017 | 2017-03-31 | −1,555.41% | −1060.83 pp |
| 2016 | 2016-03-31 | −494.58% | +29.13 pp |
| 2015 | 2015-03-31 | −523.71% | −335.51 pp |
| 2014 | 2014-03-31 | −188.20% | +102.48 pp |
| 2013 | 2013-03-31 | −290.68% | −61.62 pp |
| 2012 | 2012-03-31 | −229.06% | — |
| Fiscal quarter | Period ended | Operating margin | Change (percentage points) |
|---|---|---|---|
| Q4 2023 | 2023-03-31 | −431.44% | +1158.70 pp |
| Q4 2022 | 2022-03-31 | −28,863.20% | −22245.89 pp |
| Q3 2022 | 2021-12-31 | −14,768.63% | −14377.44 pp |
| Q2 2022 | 2021-09-30 | −1,522.21% | −658.67 pp |
| Q1 2022 | 2021-06-30 | −1,590.14% | −1378.17 pp |
| Q4 2021 | 2021-03-31 | −6,617.30% | −1396.68 pp |
| Q3 2021 | 2020-12-31 | −391.18% | +1597.46 pp |
| Q4 2020 | 2020-03-31 | −863.54% | −130.19 pp |
| Q3 2020 | 2019-12-31 | −211.97% | +1487.05 pp |
| Q1 2020 | 2019-06-30 | −5,220.63% | −3665.25 pp |
| Q4 2019 | 2019-03-31 | −1,988.65% | −1413.93 pp |
| Q1 2019 | 2018-06-30 | −733.35% | +23682.01 pp |
| Q4 2018 | 2018-03-31 | −1,699.01% | −1128.72 pp |
| Q3 2018 | 2017-12-31 | −1,555.38% | +1695.74 pp |
| Q2 2017 | 2016-09-30 | −574.72% | −449.23 pp |
| Q1 2017 | 2016-06-30 | −24,415.36% | −22130.57 pp |
| Q4 2015 | 2015-03-31 | −570.29% | −455.72 pp |
| Q3 2015 | 2014-12-31 | −3,251.12% | −1636.27 pp |
| Q2 2015 | 2014-09-30 | −125.49% | −89.86 pp |
| Q1 2015 | 2014-06-30 | −2,284.79% | −1884.07 pp |
| Q4 2014 | 2014-03-31 | −114.57% | +95.12 pp |
| Q3 2014 | 2013-12-31 | −1,614.85% | −1166.13 pp |
| Q2 2014 | 2013-09-30 | −35.63% | +164.26 pp |
| Q1 2014 | 2013-06-30 | −400.72% | +56.40 pp |
| Q4 2013 | 2013-03-31 | −209.69% | −174.07 pp |
| Q3 2013 | 2012-12-31 | −448.72% | — |
| Q2 2013 | 2012-09-30 | −199.89% | — |
| Q1 2013 | 2012-06-30 | −457.13% | — |
| Q3 2012 | 2011-12-31 | −35.63% | — |
Over the last five reported fiscal years, Aethlon Medical's operating margin increased from −3,228.82% to −2,072.05%, a change of +1156.77 percentage points. The latest reported quarter, Q4 2023, shows −431.44%.
Operating margin measures the percentage of revenue left after operating costs and expenses. It shows how much operating profit a company generates from each dollar of revenue.
TickerStat calculates operating margin as SEC-reported operating income divided by SEC-reported revenue for the same fiscal period. Changes are shown in percentage points. Fiscal periods can differ from calendar years, so exact period-end dates are included.
Review Aethlon Medical filings at SEC.gov ↗